Standex International Corporation — Form 10-Q Summary
Reporting period: Quarter and nine months ended March 31, 2024 (fiscal 2024 Q3; fiscal year ends June 30). The filing was signed May 3, 2024. Although the request metadata says “2023 Q3,” the filing covers 2024 Q3.
Financial performance
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Net sales | $177.3 million vs. $184.3 million, down 3.8% | $540.4 million vs. $552.7 million, down 2.2% |
| Gross profit / margin | $68.3 million / 38.5%, versus $70.9 million / 38.5% | $212.6 million / 39.3%, versus $211.5 million / 38.3% |
| Operating income | $21.8 million vs. $88.5 million | $74.6 million vs. $142.6 million |
| Continuing-operations income | $15.9 million vs. $80.6 million | $53.9 million vs. $119.0 million |
| Net income / diluted EPS | $15.8 million / $1.33 vs. $80.5 million / $6.77 | $53.5 million / $4.50 vs. $118.8 million / $9.97 |
| Operating cash flow | Quarterly amount not stated in the supplied filing text | $64.6 million from continuing operations, versus $50.4 million |
The prior-year comparisons for operating income and earnings include a $62.1 million pre-tax gain from the Procon sale. Excluding that unusual comparison item, the reported year-over-year declines are less pronounced; the filing does not provide a single adjusted earnings figure in the supplied text. Q3 sales fell organically, while acquisitions partly offset declines and the Procon divestiture.
SG&A was $41.8 million in Q3 and $128.6 million year to date. The effective tax rate was 21.4% for Q3 and 22.5% year to date, compared with 6.7% and 13.0%, respectively, in the prior-year periods; prior-year tax included discrete benefits, including one associated with the Procon sale.
Liquidity, debt and capital allocation
- At March 31, cash and equivalents were $138.8 million, down from $195.7 million at June 30, 2023. Of the current balance, $110.5 million was held by foreign subsidiaries; repatriation timing may depend on operational needs, exchange rates, taxes and capital controls.
- Long-term debt was $148.8 million net of issuance costs ($150.0 million funded debt), down from $173.4 million at June 30. Standex reported net debt of $10.0 million, compared with net cash of $22.3 million at fiscal year-end.
- The $500 million revolving facility had $347.3 million of borrowing capacity available, after $2.7 million of letters of credit. The company was compliant with its covenants: interest coverage was 26.12x against a 2.75x minimum, and leverage was 0.63x against a 3.5x maximum.
- Cash flow from continuing operations less capital expenditures was approximately $50.8 million for the nine months, based on $64.6 million of operating cash flow and $13.8 million of capital spending. Investing cash outflow was $54.0 million; financing cash outflow was $65.8 million.
- Uses of cash included $47.7 million of acquisition spending, $25.0 million of debt repayments, $31.8 million of treasury-stock purchases and $10.4 million of dividends. The company declared dividends of $0.88 per share year to date.
Material changes and segment trends
- Sales were down organically $10.5 million in Q3 and $20.1 million year to date. Acquisitions contributed $10.6 million in Q3 and $28.8 million year to date; the Procon divestiture reduced sales by $5.5 million and $21.3 million, respectively.
- Electronics: Q3 sales rose 2.8%, but operating income fell 7.9%; year-to-date sales rose 6.9% while operating income fell 8.2%. Acquisitions supported sales, offset by organic softness, particularly in China and Europe.
- Engraving: Q3 sales declined 1.7%, while operating income grew 16.9%. Year-to-date sales rose 7.6% and operating income 29.5%, supported by demand and productivity initiatives.
- Scientific: Q3 sales declined 10.4% and year-to-date sales declined 9.2%, reflecting market softness, including lower retail-pharmacy purchases. Productivity and freight savings supported higher operating income.
- Engineering Technologies: Q3 sales rose 11.3% and operating income 49.9%, helped by aviation demand, pricing and productivity. Year-to-date sales were down 1.8%, partly due to project timing.
- Specialty Solutions: Q3 sales declined 27.1% and year-to-date sales declined 29.5%, reflecting the Procon divestiture and weaker organic sales. The group’s Q3 operating income fell 34.7%.
- Backlog under one year was $199.2 million, down 24.7% from $264.5 million a year earlier; total backlog was $225.4 million versus $290.7 million.
Outlook, risks and unusual items
- Management expects continued improvement in key financial metrics for the remainder of fiscal 2024, supported by productivity initiatives. Its market outlook includes improving transportation, aviation and defense demand; stable vaccine and medication storage demand; and continued softness in China and Europe affecting industrial and appliance markets.
- For Q4, management expects Electronics revenue to be similar sequentially with slightly lower to similar adjusted margin; Engraving revenue and margin to be slightly lower; Scientific revenue slightly higher with similar margin; Engineering Technologies revenue moderately to significantly higher with moderately higher margin; and Specialty Solutions revenue and margin moderately higher. These are management expectations, not guarantees.
- Fiscal 2024 capital spending was expected to be $28–$32 million. The filing states expected depreciation of $20–$22 million and amortization of $8–$9 million.
- Standex acquired Minntronix for approximately $29.2 million in July 2023 and Sanyu for approximately $20.9 million net of cash acquired in February 2024. A further reed-relay distributor acquisition for approximately $5.7 million closed May 3, after quarter-end.
- Q3 restructuring costs were $4.0 million and year-to-date costs were $7.3 million; management expected about $0.4 million more during the rest of fiscal 2024. A one-time stock-compensation charge and higher research and development spending also affected expenses.
- Interest-rate exposure was hedged on $150 million of debt through swaps at a weighted fixed rate of 0.85%; the effective borrowing rate, including swaps, was 2.45%. Principal risks cited include demand and economic conditions, supply and labor availability, raw-material and freight costs, foreign exchange, tariffs, acquisition integration, restructuring savings, cybersecurity, and pension funding.
- Management said existing legal matters were not expected to materially affect financial position, results or cash flow. A contingent-consideration arrangement could require payment of up to $12.8 million if specified GS Engineering targets are met in fiscal 2024. The company also reported a $0.1 million environmental-remediation settlement charge in Q3.
Important facts for investors to verify
- Whether organic demand and backlog stabilize, especially in Electronics and the markets exposed to China and Europe softness.
- How much of the earnings decline reflects the prior-year Procon gain versus current operating performance, and whether productivity initiatives translate into sustained margin improvement.
- Integration, purchase-price accounting and performance of Minntronix and Sanyu, including Sanyu holdbacks and the post-quarter distributor acquisition.
- Cash generation and capital allocation alongside lower cash balances, share repurchases, dividends and acquisition spending; also consider the location and potential repatriation constraints on foreign cash.
- Progress against restructuring plans, the remaining fiscal 2024 capital-spending and pension-contribution expectations, and any changes in contingent consideration or other contingencies.